GoodRx Holdings, Inc. (GDRX)
| Market Cap | 796.49M |
| Revenue (ttm) | 796.85M |
| Net Income (ttm) | 30.44M |
| Shares Out | 342.57M |
| EPS (ttm) | 0.09 |
| PE Ratio | 27.22 |
| Forward PE | 25.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 789,975 |
| Open | 2.290 |
| Previous Close | 2.280 |
| Day's Range | 2.290 - 2.355 |
| 52-Week Range | 1.770 - 5.810 |
| Beta | 1.47 |
| Analysts | Buy |
| Price Target | 3.66 (+57.42%) |
| Earnings Date | May 6, 2026 |
About GDRX
GoodRx Holdings, Inc., together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices. It also offers other healthcare products and services, including subscription programs and pharma manufacturer solutions, as well as telehealth services through the GoodRx Care platform. In ad... [Read more]
Financial Performance
In 2025, GoodRx Holdings's revenue was $796.85 million, an increase of 0.57% compared to the previous year's $792.32 million. Earnings were $30.44 million, an increase of 85.72%.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for GDRX stock is "Buy." The 12-month stock price target is $3.66, which is an increase of 57.42% from the latest price.
News
GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its ...
GoodRx Rallies As Wegovy HD Rollout Targets Self-Pay Market
• GoodRx Holdings shares are advancing steadily. What's driving GDRX shares up?
GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that the new higher dose Wegovy® HD (semaglutide) injection 7.2...
GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access ...
GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced a new collaboration with Viatris, a global healthcare company, ...
GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced employer-sponsored access to Zepbound® (tirzepatide) KwikPen® (...
GoodRx Targets Digital Subscription Growth Amid 14% Dip in Active Consumers
The prescription experience has started to resemble other parts of digital commerce: shoppers want clear pricing, fewer handoffs and a quicker path from decision to fulfillment. That push toward self-...
GoodRx Holdings Earnings Call Transcript: Q4 2025
Q4 and full-year 2025 results showed stable revenue and EBITDA growth, with Pharma Direct revenue up 41% year-over-year and new subscription offerings gaining traction. 2026 guidance reflects near-term revenue pressure from strategic investments, but long-term growth is expected as Pharma Direct and subscriptions scale.
GoodRx Reports Fourth Quarter and Full Year 2025 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its f...
GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced the launch of GoodRx Employer Direct. The new offering enables ...
GoodRx Powers Pricing for Leading Brand Medications on TrumpRx
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is a key integration partner for pharmaceutical compani...
GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status for HITRUST i1 Cert...
GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its ...
GoodRx Holdings Transcript: 44th Annual J.P. Morgan Healthcare Conference
Shifts in insurance coverage and pharmacy closures are driving more consumers to seek cash savings and alternative prescription solutions. Growth is led by condition-based subscriptions and manufacturer partnerships, while a new Surescripts alliance aims to boost price transparency and adherence.
Surescripts and GoodRx Partner to Advance Patient Price Transparency
ARLINGTON, Va. & SANTA MONICA, Calif.--(BUSINESS WIRE)-- #HealthIT--Surescripts®, the nation's leading health intelligence network, introduces its Patient Experience product, Script Corner™, to transf...
GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of RxSmartSaver powered by GoodRx at Giant Eagle pharm...
GoodRx Now Offers Novo Nordisk's Cash Price for the Launch of the Wegovy® Pill
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced that the newly FDA-approved Wegovy® pill (oral semaglutide) is no...
GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for medication savings in the U.S., today announced that executives from t...
GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced two major initiatives to make FDA-approved GLP-1 medications more...
GoodRx Sees ‘Profund Transformation' in Prescriptions With TrumpRx
GoodRx CEO Wendy Barnes sees a “profound transformation” happening in prescription drug pricing. The catalyst, Barnes said during an earnings call Wednesday (Nov. 3), is the pending launch of TrumpRx,...
GoodRx Holdings Earnings Call Transcript: Q3 2025
Q3 2025 delivered solid results with $196M revenue and 54% growth in manufacturer solutions, offsetting a 9% decline in prescription transaction revenue. Strategic partnerships, new affordability programs, and a strong balance sheet position the company for long-term growth.
GoodRx Reports Third Quarter 2025 Results
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading platform for medication savings in the U.S., has released its f...
Should You Buy GoodRx Stock?
Here's why we believe GoodRx (GDRX) stock is worth considering: It is expanding, generating cash, and is available at a notable valuation discount. Let's examine the figures.
GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment
SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S., today announced the launch of a new subscription for hair loss treatment. Built f...
Trump Administration Engages Pharmacies, GoodRx For TrumpRx Launch
Prescription savings platform GoodRx Holdings Inc. (NASDAQ:GDRX) is reportedly joining the so-called TrumpRx website, signaling an initiative expansion beyond pharmaceutical manufacturers' direct disc...